Guest defense by hello entertainment12/24/2023 ![]() ![]() Visions of homeruns and Clydesdales and swing and miss curveballs danced in their heads. Louis Cardinals were all tucked neatly into their bunk beds in the room that all of them share. It was a dark and stormy night, the night of March 29, 2023. So instead I thought maybe I would share with you the four previews I guest wrote at Bleed Cubbie Blue this season (with links in the series numbers). These two teams just played each other four days ago, so it doesn’t feel like there will be much to preview that we didn’t just go over. ![]() This is upcoming series is the Cardinals and Cubs last series of the season. I had so much fun with that, I had to keep writing them that way. When he first asked me to contribute, the Cardinals’ record was foul and I did not really want to write about them, so. ![]() The stock rose 5.8% on Tuesday amid takeover talk.Al Yellon at Bleed Cubbie Blue has this really fun way of doing previews where he invites site managers from the SBNation site of the Cubs’ opponents to write a little bit about their team. Salix initially rose Wednesday to a fresh high of 172.98, but reversed to close down 1% to 167.52. "We remain convinced that your shareholders will support a combination of our two companies and that such a combination will create far more value than any alternative transaction or standalone plan.Īctavis shares rose 3% to 248.02 Wednesday, hitting a new high intraday. "While we continue to believe it's in the best interest of your shareholders for you and your team to conduct due diligence on our business, you seem intent on avoiding constructive engagement at all costs," Pearson wrote to Pyott. In a Monday letter, Pearson initially tried to soothe Allergan with talk of "tak(ing) the temperature down" with "constructive discussion" minus the "mudslinging.Ī rebuttal from Allergan prompted Pearson to send another letter on Wednesday calling Pyott's concerns "unfounded" and "disingenuous. Michael Pearson and Allergan (AGN) CEO David Pyott in which Valeant proved to be no Prince Charming in its continued, aggressive courtship of the Botox queen despite claiming to extend an "olive branch. Valeant also released correspondence between CEO J. Some analysts have speculated that 180 might be a fair price.Īllergan rose 4% to 176.28, hitting a new high. Valeant is offering $72 in cash plus 0.83 share per Allergan share - equal to 174.92 per share as of Wednesday's close. ![]()
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |